Galecto appoints Dr. Amy Wechsler to Board of Directors effective October 11, 2024

Damora Therapeutics, Inc.

Board expanded to seven members; Wechsler appointed as Class I director with term through 2027 annual meeting.
Wechsler is board-certified in dermatology and psychiatry and serves on the Bausch Health board.
She holds an M.D. from Cornell University Medical College and an M.B.A. from Columbia Business School (2024).
Wechsler is independent under Nasdaq standards and will receive standard non-employee director compensation and equity.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Amy Wechsler

Director

DMRA · Damora Therapeutics, Inc.

Effective: 2024-10-11
Filed: October 15, 2024, 7:59 PM ET

appointed Amy Wechsler to join the Board, effective as of October 11, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Amy Wechsler was appointed as Director at Damora Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Amy Wechsler to join the Board, effective as of October 11, 2024.

View on SEC.gov

Damora Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-114481

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.